Study | Reason for exclusion |
---|---|
Angus 1997 | Allocation: 'double blind'. Participants: those with a psychotic illness. Interventions: amantadine hydrochloride versus neuroleptic, not haloperidol decanoate. |
Baastrup 1993 | Allocation: randomised. Participants: those with exacerbation of chronic psychosis. Interventions: haloperidol decanoate and oral versus zuclopenthixol acetate versus zuclopenthixol decanoate. Outcomes: no usable data, haloperidol decanoate and oral data pooled. |
Bucci 1985 | Allocation: not randomised. |
Cookson 1991 | Allocation: 'double blind'. Participants: those with schizophrenia. Interventions: haloperidol decanoate versus fluphenazine decanoate. Outcomes: no usable data, authors contacted and have replied redirecting the request to a third party who has been contacted. |
Curson 1985 | Allocation: randomised. Participants: those with schizophrenia. Interventions: fluphenazine decanoate versus placebo, not haloperidol decanoate. |
Deberdt 1980 | Allocation: not randomised. |
Dencker 1980 | Allocation: randomised. Participants: those with schizophrenia. Interventions: clopenthixol depot versus flupehthixol depot, not haloperidol decanoate. |
Dencker 1994 | Allocation: randomised. Participants: those with schizophrenia. Interventions: haloperidol decanoate versus perphanazine decanoate. Outcomes: no usable data, authors contacted. |
Fernando 1984 | Allocation: not randomised. |
Gianelli 1990 | Allocation: not randomised. |
Jolley 1990 | Allocation: randomised. Participants: those with schizophrenia. Interventions: fluphenazine decanoate, not haloperidol decanoate. |
Meco 1985 | Allocation: not randomised. |
Meco 1987 | Allocation: not randomised. |
Nair 1986 | Allocation: not randomised. |
Rapp 1986 | Allocation: randomised. Participants: those with schizophrenia. Interventions: haloperidol decanoate versus perphenazine decanoate. Outcomes: no usable data, authors contacted. |
Roose 1982 | Allocation: not randomised. |
Ushakov 1990 | Allocation: randomised. Participants: those with schizophrenia. Interventions: haloperidol decanoate versus fluphenazine. Outcomes: no usable data. |
Van Putten 1986 | Allocation: not randomised. |
Varma 1989 | Allocation: not randomised. |
Wei 1996 | Allocation: not randomised. |
Weiden 1995 | Allocation: not randomised. |
Wiles 1990 | Allocation: 'double blind'. Participants: those with schizophrenia. Interventions: haloperidol decanoate versus fluphenazine decanoate. Outcomes: no usable data, authors contacted. |
Youssef 1991 | Allocation: not randomised. |
Zonda 1992 | Allocation: not randomised. |
Behaviour scale NOSIE ‐ Nurses Observation Scale for Inpatient Evaluation.